Dr. Ujjwal Neogi
Dr. Ujjwal Neogi
Verified email at
Cited by
Cited by
Gut microbiota diversity predicts immune status in HIV-1 infection
P Nowak, M Troseid, E Avershina, B Barqasho, U Neogi, K Holm, JR Hov, ...
Aids 29 (18), 2409-2418, 2015
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
S Appelberg, S Gupta, S Svensson Akusjärvi, AT Ambikan, F Mikaeloff, ...
Emerging microbes & infections 9 (1), 1748-1760, 2020
Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy
H Babu, AT Ambikan, EE Gabriel, S Svensson Akusjärvi, AN Palaniappan, ...
Frontiers in immunology 10, 1965, 2019
Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers
J Vesterbacka, J Rivera, K Noyan, M Parera, U Neogi, M Calle, R Paredes, ...
Scientific reports 7 (1), 6269, 2017
Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C
U Neogi, I Bontell, A Shet, A De Costa, S Gupta, V Diwan, RS Laishram, ...
PloS one 7 (6), e39819, 2012
The impact of human immunodeficiency virus infection on gut microbiota α-diversity: an individual-level meta-analysis
SA Tuddenham, WLA Koay, N Zhao, JR White, KG Ghanem, CL Sears
Clinical Infectious Diseases 70 (4), 615-627, 2020
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance
M Bachu, S Yalla, M Asokan, A Verma, U Neogi, S Sharma, RV Murali, ...
Journal of Biological Chemistry 287 (53), 44714-44735, 2012
Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication
S Krishnan, H Nordqvist, AT Ambikan, S Gupta, M Sperk, ...
Molecular & Cellular Proteomics 20, 2021
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased …
VR Rao, U Neogi, JS Talboom, L Padilla, M Rahman, C Fritz-French, ...
Retrovirology 10, 1-16, 2013
Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades
U Neogi, A Häggblom, M Santacatterina, G Bratt, M Gisslen, J Albert, ...
PloS one 9 (6), e99390, 2014
GS-CA compounds: first-in-class HIV-1 capsid inhibitors covering multiple grounds
K Singh, F Gallazzi, KJ Hill, DH Burke, MJ Lange, TP Quinn, U Neogi, ...
Frontiers in microbiology 10, 455764, 2019
Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy
H Babu, M Sperk, AT Ambikan, G Rachel, VK Viswanathan, SP Tripathy, ...
Metabolites 9 (10), 210, 2019
Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden
A Häggblom, V Svedhem, K Singh, A Sönnerborg, U Neogi
The lancet HIV 3 (4), e166-e174, 2016
The disproportionate effect of COVID-19 mortality on ethnic minorities: Genetics or health inequalities?
Z El-Khatib, GB Jacobs, GM Ikomey, U Neogi
EClinicalMedicine 23, 2020
Subtype‐independent near full‐length HIV‐1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management
S Grossmann, P Nowak, U Neogi
African Journal of Reproduction and Gynaecological Endoscopy 18 (1), 2015
Transcriptomics and targeted proteomics analysis to gain insights into the immune-control mechanisms of HIV-1 infected elite controllers
W Zhang, AT Ambikan, M Sperk, R van Domselaar, P Nowak, K Noyan, ...
EBioMedicine 27, 40-50, 2018
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
E Saccon, X Chen, F Mikaeloff, JE Rodriguez, L Szekely, BS Vinhas, ...
Iscience 24 (5), 2021
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
U Neogi, K Singh, SG Aralaguppe, LC Rogers, DT Njenda, SG Sarafianos, ...
Aids 32 (4), 469-476, 2018
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
WC Albrich, TS Ghosh, S Ahearn-Ford, F Mikaeloff, N Lunjani, B Forde, ...
Gut microbes 14 (1), 2073131, 2022
The system can't perform the operation now. Try again later.
Articles 1–20